Largest Meta-Analysis Suggests Higher Omega-3 Doses For Heart Health
Omega-3 supplementation results in 8% reduction in heart attack and coronary heart disease risk over a five-year period versus placebo, finds a meta-analysis in JAMA. Encompassing 120,000 patients, research updates recent meta-analyses with addition of three studies in past year, two casting doubt on heart health benefits of omega-3s.
You may also be interested in...
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
US and Europe led in 2019 sales of omega-3-fortified products worldwide, a market valued at $44bn that has extended beyond supplements and baby formulas to include foods, beverages and pet food, says GOED in report released 26 May. As the US market is ‘mature,’ its sales growth is expected at 5.8% in 2021, while sales of less mature markets such as Asia (excluding China) is anticipated to climb 12.6%.
US Wellness Market In 2019: Amarin Wins, Loses On Supplements; Gottlieb Leaves With Consumer Health Flourish
Looking look back on US wellness market developments and events in 2019, HBW Insight finds a firm that doesn’t compete in the dietary supplement sector, Amarin, made a good bit of news that affected the industry during the year. We track news across the wellness space from the past year.